In the News | Charles River
   
 
 
   
   

Outsourcing & Vaccines
All signs point to growth for vaccine services
Contract Pharma – November/December 2009

During the past decade, a number of major pharma companies entered the vaccine market, growing through internal investment or acquisition. At the same time, we’ve seen a burst of vaccine-focused biotech startups. The surge of interest in this field is no surprise; according to a report from Scientia Advisors, worldwide sales of vaccines are expected to rise from $16 billion in 2007 to $35 billion in 2014. (This covers both prophylactic and therapeutic vaccines.) It’s also been a decade of panic; from biodefense to SARS to avian flu and now the swine flu pandemic, there’s been a seismic shift in vaccine funding this decade...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.